ASSET PURCHASE AGREEMENTAsset Purchase Agreement • September 30th, 2022 • SciSparc Ltd. • Pharmaceutical preparations • Delaware
This Asset Purchase Agreement (this “Agreement”) is made and entered into effect as of September 12, 2022 (the “Effective Date”), by and among: (i) SciSparc Ltd., an Israeli publicly traded company (“Parent”), acting for itself or for its wholly owned subsidiary, SciSparc Nutraceuticals Inc., a Delaware corporation (“Sub” and together with Parent, “Buyer”); (ii) [**] (“Seller”); (iii) [**], an individual; (iv) [**], an individual; and (v) [**], an individual; [**] shall collectively be referred to as “Owners”).
SciSparc Ltd. Share Purchase WarrantWarrant • September 30th, 2022 • SciSparc Ltd. • Pharmaceutical preparations
ASSIGNMENT AND ASSUMPTION AGREEMENTAssignment and Assumption Agreement • September 30th, 2022 • SciSparc Ltd. • Pharmaceutical preparations
THIS ASSIGNMENT AND ASSUMPTION AGREEMENT (the “Agreement”) is made and entered into this 12 day of September 2022, (the “Effective Date”) by and between M.R.M. Merhavit Holdings and Management Ltd. (the “Buyer”), and SciSparc Ltd. (“Assignee”) (hereinafter referred to collectively as the “Parties” and individually as a “Party”).
